fbpx

Discovery Platform
From Target to Market

Discovery Services

Proven Chemistry

Screening Libraries
Compounds & libraries eShop

Pharmaceutical
Development

Pharmaceutical Development

Why Choose ChemDiv?

  • 25 years experience and 2500 customers worldwide
  • Premium R&D CRO based in USA with global reach
  • Seasoned project managers
  • Extensive Academic partnerships
  • Flexible business models
  • Industry's largest ever-greening stock compound inventory
  • Ongoing investments in novel proprietary chemistry and discovery platforms
Learn More About Us

Our Blog

FEBRUARY IS HEART HEALTH
AWARENESS MONTH
Heart disease is the leading cause of death globally, and 15 million people suffer stroke ...
Read More
CHEMDIV GOES MOBILE
We are happy to announce that from now on you can pay by credit cards online. Easy ...
Read More
NOTUM
(WNT SIGNALING) LIBRARY
ChemDiv presents a brand new library – NOTUM (Wnt Signaling) Library, which consists of over 4,000 compounds. ...
Read More
Read Our News >

Pharma News

Japan’s Takeda sells four diabetes products to Teijin Pharma for $1.25 billion
February 26, 2021
Pfizer to test third dose, tweaked vaccine to target S.African strain
February 26, 2021
Alzheimer’s may strike women and men in different ways
February 26, 2021
Read All Pharma News >

New Products &Services

Target Activity profiling library
MCE-18 Trends in MedChem
Covalent Inhibitors library
RNA Trinucleotide mimetics
X
Send a message
Request a call

    * Required fields

    By submitting this form you confirm that you have read and accepted our privacy policy. Your data will be used exclusively for this purpose.

      * Required fields

      By submitting this form you confirm that you have read and accepted our privacy policy. Your data will be used exclusively for this purpose.

      X